Total Payments
$110,567
2024 Payments
$48,116
Companies
50
Transactions
585
Medicare Patients
4,467
Medicare Billing
$1.9M
Payment Breakdown by Category
Other$59,713 (54.0%)
Consulting$20,645 (18.7%)
Food & Beverage$15,733 (14.2%)
Travel$14,314 (12.9%)
Education$163.24 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $59,353 | 18 | 53.7% |
| Consulting Fee | $20,645 | 7 | 18.7% |
| Food and Beverage | $15,733 | 504 | 14.2% |
| Travel and Lodging | $14,314 | 47 | 12.9% |
| Honoraria | $360.00 | 1 | 0.3% |
| Education | $163.24 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $74,866 | 109 | $0 (2024) |
| Insmed, Inc. | $6,764 | 10 | $0 (2024) |
| Theravance Biopharma Inc. | $6,758 | 10 | $0 (2017) |
| Mylan Specialty L.P. | $4,075 | 13 | $0 (2024) |
| Hill-Rom Company, Inc | $1,760 | 1 | $0 (2021) |
| PFIZER INC. | $1,695 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,425 | 2 | $0 (2018) |
| CSA Medical, Inc | $1,289 | 3 | $0 (2019) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $1,054 | 40 | $0 (2024) |
| Allergan, Inc. | $981.39 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,116 | 103 | Gilead Sciences, Inc. ($46,627) |
| 2023 | $21,151 | 109 | Gilead Sciences, Inc. ($18,900) |
| 2022 | $15,634 | 109 | Gilead Sciences, Inc. ($6,857) |
| 2021 | $5,780 | 70 | Gilead Sciences, Inc. ($2,482) |
| 2020 | $3,703 | 58 | Mylan Specialty L.P. ($1,945) |
| 2019 | $3,266 | 45 | Mylan Specialty L.P. ($2,002) |
| 2018 | $1,352 | 46 | Mallinckrodt LLC ($280.46) |
| 2017 | $11,566 | 45 | Theravance Biopharma Inc. ($6,758) |
All Payment Transactions
585 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: ANTIBIOTIC | ||||||
| 12/05/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: HFCWO | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,810.00 | General |
| Category: COVID-19 | ||||||
| 12/03/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Medical Device | ||||||
| 12/01/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,780.00 | General |
| Category: COVID-19 | ||||||
| 11/27/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ANTIBIOTIC | ||||||
| 11/26/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $56.28 | General |
| Category: COVID-19 | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,780.00 | General |
| Category: COVID-19 | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $840.00 | General |
| Category: COVID-19 | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $124.36 | General |
| Category: COVID-19 | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $1,102.15 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $640.63 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $176.56 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $58.99 | General |
| Category: COVID-19 | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Airway Clearance Device | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,780.00 | General |
| Category: COVID-19 | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $352.90 | General |
| Category: COVID-19 | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $298.74 | General |
| Category: COVID-19 | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $129.32 | General |
| Category: COVID-19 | ||||||
| 11/05/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $44.82 | General |
| Category: Airway Clearance Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 798 | 3,378 | $1.3M | $366,623 |
| 2022 | 9 | 989 | 4,048 | $1.6M | $410,801 |
| 2021 | 11 | 1,356 | 5,308 | $2.1M | $552,502 |
| 2020 | 15 | 1,324 | 4,782 | $2.0M | $528,974 |
Total Patients
4,467
Total Services
17,516
Medicare Billing
$1.9M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 217 | 2,609 | $1.0M | $259,735 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 210 | 267 | $116,145 | $38,557 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 154 | $50,050 | $22,670 | 45.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 85 | 115 | $45,309 | $20,152 | 44.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 60 | 96 | $31,200 | $10,925 | 35.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $13,125 | $6,596 | 50.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $9,750 | $3,767 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 19 | $4,750 | $1,554 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $3,250 | $1,326 | 40.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 13 | 13 | $1,950 | $679.25 | 34.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 13 | 13 | $650.00 | $509.60 | 78.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 18 | $288.00 | $151.20 | 52.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 341 | 3,100 | $1.2M | $268,711 | 22.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 327 | 371 | $161,385 | $61,482 | 38.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 53 | 206 | $101,000 | $37,932 | 37.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 97 | $31,550 | $15,298 | 48.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 56 | 93 | $30,225 | $11,333 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $9,375 | $4,797 | 51.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 31 | $7,700 | $3,352 | 43.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $7,125 | $2,966 | 41.6% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2022 | 31 | 46 | $13,800 | $2,182 | 15.8% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Facility | 2022 | 18 | 27 | $8,100 | $1,187 | 14.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 16 | 17 | $2,550 | $928.16 | 36.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 15 | 16 | $800.00 | $631.20 | 78.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 498 | 3,914 | $1.5M | $344,677 | 22.9% |
About Dr. Ashraf Elsayegh, MD
Dr. Ashraf Elsayegh, MD is a Sleep Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073684056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashraf Elsayegh, MD has received a total of $110,567 in payments from pharmaceutical and medical device companies, with $48,116 received in 2024. These payments were reported across 585 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($59,353).
As a Medicare-enrolled provider, Elsayegh has provided services to 4,467 Medicare beneficiaries, totaling 17,516 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Los Angeles, CA
- Active Since 11/13/2006
- Last Updated 01/26/2026
- Taxonomy Code 207RS0012X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073684056
Products in Payments
- Veklury (Drug) $74,206
- Arikayce (Drug) $6,764
- Yupelri (Drug) $4,013
- ELIQUIS (Drug) $3,099
- VIBATIV (Drug) $2,203
- Volara System (Device) $1,760
- ACTHAR (Biological) $1,232
- Hillrom - Vest System Model 105 Home Care (Device) $719.33
- RADICAVA (Drug) $682.09
- TEFLARO (Drug) $645.56
- DUPIXENT (Biological) $579.77
- NUZYRA (Drug) $576.17
- The Vest System Model 105 Home Care (Device) $493.93
- TEZSPIRE (Biological) $453.83
- Prolastin-C Liquid (Biological) $384.17
- Radicava (Drug) $371.85
- The Vest System 205 Acute Care (Device) $360.00
- TRELEGY ELLIPTA (Drug) $343.12
- OFEV (Drug) $334.09
- GIAPREZA (Drug) $323.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sleep Medicine Doctors in Los Angeles
Alon Avidan, Md, MD
Sleep Medicine — Payments: $355,031
Sleep Medicine $355,031
Marilene Wang, Md, MD
Sleep Medicine — Payments: $18,217
Sleep Medicine $18,217
Dr. Arun Ramachandran, Md, MD
Sleep Medicine — Payments: $17,207
Sleep Medicine $17,207
Payam Shadi, M.d, M.D
Sleep Medicine — Payments: $14,855
Sleep Medicine $14,855
Christine Mcelyea, Do, DO
Sleep Medicine — Payments: $2,285
Sleep Medicine $2,285
Tammy Wong
Sleep Medicine — Payments: $1,714
Sleep Medicine $1,714